Lisobil 2 Miu Injection – Precision in Infection Control – for Strong Antimicrobial Defense.
Lisobil 2 Miu Injection – The Combination of Colistimethate Sodium Injection IP 2 Million is an antibiotic primarily used to treat life-threatening infections caused by multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa and Acinetobacter baumannii. Upon administration, colistimethate sodium is converted in the body to colistin, the active form that exerts its bactericidal effects.
Key Benefits of Colistimethate Sodium Injection IP 2 Million IU – Lisobil 2 Miu Injection
✅Broad-Spectrum Activity Against Gram-Negative Pathogens: Targets tough acquired organisms such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.
✅Bactericidal Action: Acts by disrupting bacterial cell membranes, leading to rapid bacterial cell death.
✅High-Impact Therapy: Preserves effectiveness by preventing antibiotic overuse and resistance spread through targeted use under specialist guidance.
Recommended By Specialists:
👨⚕️Infectious Disease Specialists: It is often prescribed for managing multidrug-resistant (MDR) bacterial infections, especially when other antibiotics are ineffective.
👨⚕️Pulmonologists: It’s used to treat hospital-acquired pneumonia and chronic pulmonary infections, particularly in conditions like cystic fibrosis, often administered via nebulization.
👨⚕️Internal Medicine Physicians: It is utilized for managing complicated infections in inpatient settings, guided by culture and sensitivity.
INDICATIONS:
✅Complicated urinary tract infections (UTIs)
✅Bloodstream infections (bacteremia)
✅Acute respiratory distress syndrome (ARDS)